Sign in
4

Changes in Ownership

Gossamer Bio, Inc. Filed Acc 0001728117-23-000053

Options or other derivatives

  • COO/CFO acquired 481,001 shares (grant or award)
  • COO/CFO returned 721,500 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Giraudo Bryan COO/CFO 2023-05-05 Returned to the company · Stock Option (Right to Buy) −145,000 0 D: show line 1 in the form
Giraudo Bryan COO/CFO 2023-05-05 Returned to the company · Stock Option (Right to Buy) −71,500 0 D: show line 2 in the form
Giraudo Bryan COO/CFO 2023-05-05 Returned to the company · Stock Option (Right to Buy) −90,000 0 D: show line 3 in the form
Giraudo Bryan COO/CFO 2023-05-05 Returned to the company · Stock Option (Right to Buy) −150,000 0 D: show line 4 in the form
Giraudo Bryan COO/CFO 2023-05-05 Returned to the company · Stock Option (Right to Buy) −265,000 0 D: show line 5 in the form
Giraudo Bryan COO/CFO 2023-05-05 Grant or award · Stock Option (Right to Buy) +96,667 96,667 D: show line 6 in the form
Giraudo Bryan COO/CFO 2023-05-05 Grant or award · Stock Option (Right to Buy) +47,667 47,667 D: show line 7 in the form
Giraudo Bryan COO/CFO 2023-05-05 Grant or award · Stock Option (Right to Buy) +60,000 60,000 D: show line 8 in the form
Giraudo Bryan COO/CFO 2023-05-05 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D: show line 9 in the form
Giraudo Bryan COO/CFO 2023-05-05 Grant or award · Stock Option (Right to Buy) +176,667 176,667 D: show line 10 in the form
Loading xslF345X04/wf-form4_168366328309495.xml…